Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study

Journal of Rheumatology

Volumn 32, Issue 3, 2005, Pages 502-506

  Gonzalez Gay, Miguel A ^a   Rubiera, Gerardo ^b   Piñeiro, Angela ^a   Garcia Porrua, Carlos ^a   Pego Reigosa, Robustiano ^a   Gonzalez Juanatey, Carlos ^a   Sanchez Andrade, Amalia ^a   Llorca, Javier ^b  

^a HOSPITAL XERAL CALDE   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Giant cell arteritis; Ischemic heart disease; Mortality; Predictors; Temporal artery biopsy

Indexed keywords

AGED; ARTICLE; BLOOD VESSEL BIOPSY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GIANT CELL ARTERITIS; HAZARD ASSESSMENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; MEDICAL ASSESSMENT; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME;

AGED; BIOPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; SURVIVAL ANALYSIS; TEMPORAL ARTERIES; TEMPORAL ARTERITIS;

EID: 15044340683     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001;27:729-49.
2. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347:261-71.
3. Lie JT and the Members and Consultants of the American College of Rheumatology Subcommittee on Classification of Vasculitis. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 1990;33:1074-87.
4. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978;88:162-7.
5. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000;79:283-92.
6. Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis. Predictors and response to treatment. Arthritis Rheum 1998;41:1497-504.
7. Caselli RJ, Hunder GG. Neurologic aspects of giant cell (temporal) arteritis. Rheum Dis Clin North Am 1993;19:941-53.
8. Reich KA, Giansiracusa DF, Strongwater SL. Neurologic manifestations of giant cell arteritis. Am J Med 1990;89:67-72.
9. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003;48:3522-31.
10. Gonzalez-Gay MA, Garcia-Porrua C, Piñeiro A, Pego-Reigosa A, Llorca J, Hunder GG. Aortic aneurysm and dissection biopsyproven giant cell arteritis from Northwest Spain. A population-based study. Medicine (Baltimore) 2004;83:335-41.
11. Lie JT. Coronary vasculitis. A review in the current scheme of classification of vasculitis. Arch Pathol Lab Med 1987;111:224-33.
12. Uddhammar A, Eriksson A-L, Nyström L, Stenling R, Rantapää-Dahlqvist S. Increased mortality due to cardiovascular disease in GCA in Northern Sweden. J Rheumatol 2002;29:737-42.
13. Freddo T, Price M, Kase C, Goldstein MP. Myocardial infarction and coronary artery involvement in giant cell arteritis. Optom Vis Sci 1999;76:14-8.
14. Martin JF, Kittas C, Triger DR. Giant cell arteritis of coronary arteries causing myocardial infarction. Br Heart J 1980;43:487-9.
15. Paulley JW. Coronary ischaemia and occlusion in giant cell (temporal) arteritis. Acta Med Scand 1980;208:257-63.
16. Strachan RW, How J, Bewsher PD. Masked giant-cell arteritis. Lancet 1980;1:194-6.
17. Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in the adults in Northwestern Spain, 1988-97. Clinical and epidemiological aspects. Medicine (Baltimore) 1999;78:292-308.
18. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M. Polymyalgia rheumatica in biopsy-proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol 1998;25:1750-5.
19. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M, Dababneh A, Hajeer A, Ollier WER. The spectrum of polymyalgia rheumatica in Northwestern Spain: Incidence and analysis of variables associated with relapse in a ten year-study. J Rheumatol 1999;26:1326-32.
20. Nordborg E, Bengtsson BA. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ 1989;299:549-50.
21. Save-Soderbergh J, Malmvall BE, Andersson R, Bengtsson BA. Giant cell arteritis as a cause of death. Report of nine cases. JAMA 1986;255:493-6.
22. Bengtsson BA, Malmvall BE. Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids. Acta Med Scand 1981;209:337-45.
23. Gonzalez-Gay MA, Blanco R, Abraira V, et al. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol 1997;24:2171-6.
24. Brack A, Rittner HL, Younge BR, Kaltschmidt C, Weyand CM, Goronzy JJ. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. J Clin Invest 1997;99:2842-50.